Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson’s disease
View ORCID ProfileHarry Costello, View ORCID ProfileAnette-Eleonore Schrag, View ORCID ProfileRobert Howard, View ORCID ProfileJonathan P. Roiser
doi: https://doi.org/10.1101/2023.06.30.23292073
Harry Costello
1Institute of Cognitive Neuroscience, University College London, London, UK
MSc, MRCPsychAnette-Eleonore Schrag
3Division of Psychiatry, University College London, London, UK
PhD, MRCPRobert Howard
2Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, UK
M.D, MRCPsychJonathan P. Roiser
1Institute of Cognitive Neuroscience, University College London, London, UK
MA, PhD
Posted June 30, 2023.
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson’s disease
Harry Costello, Anette-Eleonore Schrag, Robert Howard, Jonathan P. Roiser
medRxiv 2023.06.30.23292073; doi: https://doi.org/10.1101/2023.06.30.23292073
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12782)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (391)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6981)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)